IOLYX THERAPEUTICS
Live / Allowed — Published for opposition (as of 25 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99566643
- Mark type
- Design + words
- Filed
- 26 Dec 2025
- Published for opposition
- 25 Aug 2026
- Attorney of record
- Todd S. Bontemps
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of ophthalmological, immunological, and inflammatory diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Medical and scientific research in the field of in the field of pharmaceutical development; Providing scientific information in the field of pharmaceutical development, namely, providing information about scientific research related to development of pharmaceuticals; Medical and scientific research information in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
Owner
- Iolyx Therapeutics, Inc., Burlingame, CA, US
- Iolyx Therapeutics, Inc., Burlingame, CA, US
Prosecution history
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 21 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 May 2026 — NON-FINAL ACTION E-MAILED
- 08 May 2026 — NON-FINAL ACTION WRITTEN
- 27 Apr 2026 — ASSIGNED TO EXAMINER